Dr. Farida Ahangari is an Assistant Professor of Medicine at the Yale School of Medicine in the Section of Pulmonary, Critical Care, and Sleep Medicine. She leads multidisciplinary preclinical and collaborative studies focused on advancing novel therapies for fibrotic lung diseases. Dr. Ahangari also serves as Director of Targeted Drug Delivery and Therapeutic Modeling, where she develops and oversees innovative translational models and drug delivery strategies within the section.
Her research focuses on bridging mechanistic discovery with translational applications. She has particular expertise in ex vivo experimental systems, including precision-cut lung slices (PCLS), which allow investigators to evaluate candidate therapies in physiologically relevant human tissue environments. Through these approaches, Dr. Ahangari aims to accelerate the development of precision therapies for patients with chronic lung diseases.
In this webinar, Dr. Ahangari will:
– Explain the importance of selecting appropriate research models to ensure reliable predictions and meaningful outcomes in drug discovery and biomedical research
– Discuss how emerging technologies are advancing research and development by improving the accuracy, efficiency, and innovation of experimental and analytical approaches
– Demonstrate the value of testing findings in human samples and advanced translational models such as precision-cut lung slices (PCLS) to confirm translational relevance and gain realistic insights into human biology and clinical applications